You are about to leave this website for another external website. Gamida Cell has no responsibility for the content of such other sites and is not liable for any damages or injury arising from that content. Any links to other sites are provided merely as a convenience to the users of this website.
1470408328882835467
Today at the @ASH_hematology Annual Meeting & Exposition, we will share 2-year outcomes and updates on our Phase 1 study of GDA-201 in combination with rituximab in patients with non-Hodgkin lymphoma.
Learn more here: https://t.co/CqDKW33SIU
#ASH21 https://t.co/pgBgXQW97J